Stocktoria
Tvardi Therapeutics, Inc. TVRD
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-01-31
Tvardi Therapeutics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | -393.8% | -579.4% | -209.1% | -386.8% | 4.0% | -561.6% | -574.5% | -6529.6% | -67907.0% |
| Net margin | — | -411.9% | -565.2% | -204.2% | -384.1% | 6.2% | -534.9% | -549.5% | -6380.4% | -66604.7% |
| FCF margin | — | -271.1% | -450.5% | -188.2% | -261.1% | -4.3% | -549.3% | -166.1% | -6024.7% | -55927.9% |
| Return on assets | -56.8% | -83.5% | -94.2% | -46.9% | -35.8% | 3.1% | -45.7% | -38.8% | -59.9% | -89.7% |
| Return on equity | -87.0% | 32.3% | 191.0% | -53.8% | -38.9% | 3.4% | -57.0% | -55.4% | -67.0% | -112.9% |
| Current ratio | 2.86 | 3.06 | 4.54 | 7.20 | 9.84 | 10.55 | 3.86 | 4.16 | 11.18 | 5.33 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.